Notice of Reduction of Tariffs on Patented Pharmaceuticals and Pharmaceutical Ingredients for Products of the United Kingdom Implemented by Presidential Proclamation 11020
Published
Why it matters
This notice revises the tariff rate on patented pharmaceuticals and associated pharmaceutical ingredients that are products of the United Kingdom from 10 percent to zero percent in accordance with Proclamation 11020 "Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States."
mail Subscribe to BIS email updates
Primary sources. No fluff. Straight to your inbox.